Literature DB >> 32416673

Transcription/Expression of KLRB1 Gene as A Prognostic Indicator in Human Esophageal Squamous Cell Carcinoma.

Guangwei Zhang1, Ying Liu1, Fajin Dong1, Xianming Liu1.   

Abstract

AIM AND
OBJECTIVE: Esophageal squamous cell carcinoma (ESCC) is the most prevalent type of cancer with worldwide distribution and dismal prognosis despite ongoing efforts to improve treatment options. Therefore, it is essential to determine the prognostic factors for ESCC. METHODS AND
RESULTS: We determined KLRB1 to be a prognostic indicator of human ESCC. KLRB1 was expressed at low levels in ESCC patients. Based on the risk score, patients were divided into high and low-risk groups. High-risk patients showed a poor survival rate. The prediction model based on the N stage, sex, and KLRB1 was significantly better than that based on the N stage and sex. The modified prediction model showed a robust ROC curve with an AUC value of 0.973. The knockdown of KLRB1 inhibited the growth of human ESCC cells. KLRB1 regulated Akt, mTOR, p27, p38, NF-κB, Cyclin D1, and JNK signaling, which was consistent with the result of GSEA.
CONCLUSION: KLRB1 is a potential prognostic marker for human ESCC patients. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.

Entities:  

Keywords:  ESCC; KLRB1; prediction model; prognosis; survival; treatment

Mesh:

Substances:

Year:  2020        PMID: 32416673     DOI: 10.2174/1386207323666200517114154

Source DB:  PubMed          Journal:  Comb Chem High Throughput Screen        ISSN: 1386-2073            Impact factor:   1.339


  2 in total

1.  Systematic Pan-Cancer Analysis of KLRB1 with Prognostic Value and Immunological Activity across Human Tumors.

Authors:  Xin Cheng; Yucheng Cao; Xiaowei Wang; Lin Cheng; Yaqiong Liu; Jun Lei; Weijun Peng; Dazun Shi
Journal:  J Immunol Res       Date:  2022-01-03       Impact factor: 4.818

2.  Key Genes Associated with Tumor-Infiltrating Non-regulatory CD4- and CD8-Positive T Cells in Microenvironment of Hepatocellular Carcinoma.

Authors:  Zijun Zhao; Chaonan Wang; Peishan Chu; Xin Lu
Journal:  Biochem Genet       Date:  2022-01-29       Impact factor: 2.220

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.